Gender
Item
female
boolean
C0079399 (UMLS CUI [1])
Age
Item
age 25 years or greater
boolean
C0001779 (UMLS CUI [1])
Genetic Predisposition
Item
genetic predisposition as defined by one of the following:
boolean
C0314657 (UMLS CUI [1])
BRCA1 gene mutation Deleterious | BRCA2 gene mutation Deleterious | BRCA1 gene mutation Significance undetermined | BRCA2 gene mutation Significance undetermined
Item
known brca1 or brca2 mutation (deleterious or uncertain significance) or
boolean
C1511022 (UMLS CUI [1,1])
C2985436 (UMLS CUI [1,2])
C1511024 (UMLS CUI [2,1])
C2985436 (UMLS CUI [2,2])
C1511022 (UMLS CUI [3,1])
C1272585 (UMLS CUI [3,2])
C1511024 (UMLS CUI [4,1])
C1272585 (UMLS CUI [4,2])
brca gene Deleterious Mutation | First Degree Relative Tested
Item
untested first-degree relative of an individual with a known deleterious brca mutation or
boolean
C0596223 (UMLS CUI [1,1])
C2985436 (UMLS CUI [1,2])
C1517194 (UMLS CUI [2,1])
C0392366 (UMLS CUI [2,2])
Patient affected | First Degree Relative Affected | Hereditary Breast and Ovarian Cancer Syndrome Test | Hereditary Breast and Ovarian Cancer Syndrome Test Negative | Breast Cancer, hereditary | Ovarian Carcinoma Hereditary | bilateral breast cancer | Age
Item
unaffected first-degree relative of an affected individual within a hereditary breast-ovarian kindred in which no testing has been performed or testing is negative, defined as: 3 or more women in 2 generations affected with breast or ovarian cancer. women with bilateral breast cancer and woman with both breast and ovarian cancer count as single individual and 1 woman must be first-degree relative of the other two, or related to the other two through a male and at least 1 woman affected with breast cancer before age 50 or ovarian cancer at any age
boolean
C0522476 (UMLS CUI [1])
C1517194 (UMLS CUI [2,1])
C0392760 (UMLS CUI [2,2])
C0677776 (UMLS CUI [3,1])
C0392366 (UMLS CUI [3,2])
C0677776 (UMLS CUI [4,1])
C0392366 (UMLS CUI [4,2])
C0205160 (UMLS CUI [4,3])
C0346153 (UMLS CUI [5])
C0029925 (UMLS CUI [6,1])
C0439660 (UMLS CUI [6,2])
C0281267 (UMLS CUI [7])
C0001779 (UMLS CUI [8])
Comprehension English Language Questionnaire | Completion English Language Questionnaire
Item
able to understand and complete english-language questionnaires
boolean
C0162340 (UMLS CUI [1,1])
C0376245 (UMLS CUI [1,2])
C0034394 (UMLS CUI [1,3])
C0205197 (UMLS CUI [2,1])
C0376245 (UMLS CUI [2,2])
C0034394 (UMLS CUI [2,3])
Clinical Study Follow-up Willing | Follow-up Radiographic Willing
Item
intend to receive clinical and radiographic follow-up at mskcc
boolean
C3274571 (UMLS CUI [1,1])
C0600109 (UMLS CUI [1,2])
C3274571 (UMLS CUI [2,1])
C0444708 (UMLS CUI [2,2])
C0600109 (UMLS CUI [2,3])
Clinical Study Follow-up | Follow-up Radiographic
Item
women will not be excluded if they have previously received clinical and radiographic follow-up at either mskcc or another institution.
boolean
C3274571 (UMLS CUI [1])
C3274571 (UMLS CUI [2,1])
C0444708 (UMLS CUI [2,2])
Breast Carcinoma | Ovarian Carcinoma
Item
prior history of breast or ovarian cancer
boolean
C0678222 (UMLS CUI [1])
C0029925 (UMLS CUI [2])
Medical contraindication Magnetic resonance imaging of breast | Aneurysm clip | Artificial cardiac pacemaker | Cochlear Implants | Claustrophobia Severe | Body Weight | Medical contraindication Paramagnetic Contrast Agent | IgE-mediated hypersensitivity | Anemia, Sickle Cell | Kidney Failure
Item
contraindication to breast mri examination (e.g. aneurysm clips, pacemaker, cochlear implant, severe claustrophobia, weight over 300 pounds) or to paramagnetic contrast (prior ige-type allergic reaction, sickle cell anemia, renal failure)
boolean
C1301624 (UMLS CUI [1,1])
C0344104 (UMLS CUI [1,2])
C0179977 (UMLS CUI [2])
C0030163 (UMLS CUI [3])
C0009199 (UMLS CUI [4])
C0008909 (UMLS CUI [5,1])
C0205082 (UMLS CUI [5,2])
C0005910 (UMLS CUI [6])
C1301624 (UMLS CUI [7,1])
C2917410 (UMLS CUI [7,2])
C0020523 (UMLS CUI [8])
C0002895 (UMLS CUI [9])
C0035078 (UMLS CUI [10])
Pregnancy | Pregnancy, Planned | Serum Beta-HCG Test Negative | radiologic examination
Item
pregnant or planning to begin attempts at conception within 1 year of enrollment. a negative serum β-hcg will not be required for study entry, nor for radiographic examination, as this test is not routinely performed before clinically indicated radiographic study.
boolean
C0032961 (UMLS CUI [1])
C0032992 (UMLS CUI [2])
C1255526 (UMLS CUI [3,1])
C0205160 (UMLS CUI [3,2])
C0043299 (UMLS CUI [4])
Clinical Study Follow-up Unable | Follow-up Radiographic Unable
Item
unable for physical, psychological, or financial reasons to receive clinical and radiographic follow-up at mskcc
boolean
C3274571 (UMLS CUI [1,1])
C1299582 (UMLS CUI [1,2])
C3274571 (UMLS CUI [2,1])
C0444708 (UMLS CUI [2,2])
C1299582 (UMLS CUI [2,3])
Comorbidity Study Subject Participation Status Limited
Item
concurrent medical or psychological conditions that, in the opinion of the attending physician or principal investigator, would place the subject at risk were she to participate
boolean
C0009488 (UMLS CUI [1,1])
C2348568 (UMLS CUI [1,2])
C0439801 (UMLS CUI [1,3])